Pharmsville Co., Ltd.

A318010

KR7318010006

Food Processing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
6,610 ^KRW	+0.15%		-1.78%	-23.58%

Mar. 18	Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI
Mar. 18	Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI

Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.

March 17, 2024 at 09:25 pm EDT

From October 1, 2023 to December 31, 2023, the company has repurchased 91,696 shares, representing 1.17% for KRW 776.85 million. With this, the company has completed the repurchase of 96,441 shares, representing 1.23% for KRW 816.11 million under the buyback announced on September 15, 2023.

Latest news about Pharmsville Co., Ltd.

Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Mar. 17	CI
Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Mar. 17	CI
Pharmsville Co., Ltd.'s Equity Buyback announced on September 15, 2023, has expired with 118,212 shares, representing 1.51% for KRW 998.83 million.	Mar. 14	CI
Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Dec. 19	CI
Pharmsville Co., Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.	23-09-15	CI
Pharmsville Co., Ltd. authorizes a Buyback Plan.	23-09-14	CI
Pharmsville Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on March 26, 2020.	20-09-28	CI
Pharmsville Co., Ltd.'s Equity Buyback announced on March 26, 2020, has expired with 82,908 shares, representing 1.09% for KRW 998.09 million.	20-09-25	CI
Tranche Update on Pharmsville Co., Ltd.'s Equity Buyback Plan announced on March 26, 2020.	20-06-28	CI
Pharmsville Co., Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.	20-03-26	CI
Pharmsville Co., Ltd. authorizes a Buyback Plan.	20-03-25	CI
FLY GANGWON Co., Ltd. announced that it has received KRW 3 billion in funding from Pharmsville Co.,Ltd.	19-12-05	CI
FLY GANGWON Co., Ltd. announced that it expects to receive KRW 3 billion in funding from Pharmsville Co.,Ltd.	19-12-04	CI
Pharmsville Co., Ltd. has completed an IPO in the amount of KRW 25.3575 billion.	19-10-15	CI
Pharmsville Co., Ltd. has filed an IPO.	19-05-14	CI

Chart Pharmsville Co., Ltd.

Duration

Period

More charts

Company Profile

Pharmsville Co., Ltd. is a Korea-based company principally engaged in the manufacturing and distribution of diet and health food. The Company manufactures and sells diet products under the brand name of Devil Diet. In addition, the Company manufactures and sells joint health, skin health supplement, eye health, nutritional supplement, immunity and antioxidation supplement food and other health functional food under the brand name of Apple Tree Dr. Kim, Vitamin Story, Apple Tree, Golden Garden, Apple Kinder, Daily Green and others. Moreover, the Company also manufactures and sells cosmetics and quasi drugs under the brand name of Doctorâs Answer.

Sector

Food Processing

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
PHARMSVILLE CO., LTD.	-23.58%	37.11M
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
BELLRING BRANDS, INC.	+1.64%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
JAMIESON WELLNESS INC.	-16.45%	802M